Purchases and Sales Made in Q2 2024 in Edgewise Therapeutics, Inc. (EWTX)
This table provides information about the institutional ownership of Edgewise Therapeutics, Inc. (EWTX) during Q2 2024. The information is specifically focused on institutions that hold shares of Edgewise Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 15, 2024
Q2 2024
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
- |
-10.1K- 37.57% |
$152K - $214K
|
16.8K
$497K
|
|
|
Aug 13, 2024
Q2 2024
|
Ubs Group Ag
|
SELL
|
- |
-13.6K- 18.36% |
$205K - $289K
|
60.5K
$1.79M
|
|
|
Aug 12, 2024
Q2 2024
|
Citigroup Inc
|
SELL
|
- |
-13.9K- 37.6% |
$209K - $295K
|
23.1K
$683K
|
|
|
Jul 30, 2024
Q2 2024
|
Mirae Asset Global Investments Co., Ltd.
|
SELL
|
- |
-14.5K- 83.9% |
$219K - $309K
|
2.79K
$82.6K
|
|
|
Aug 14, 2024
Q2 2024
|
Dafna Capital Management LLC
Los Angeles, CA |
SELL
|
- |
-16K- 5.23% |
$241K - $340K
|
290K
$8.6M
|
|
|
Aug 14, 2024
Q2 2024
|
Kennedy Capital Management, Inc.
St Louis, MO |
SELL
|
- |
-21.2K- 7.23% |
$320K - $450K
|
272K
$8.06M
|
|
|
Aug 14, 2024
Q2 2024
|
Two Sigma Investments, LP
New York, NY |
SELL
|
- |
-30.2K- 7.68% |
$455K - $640K
|
363K
$10.7M
|
|
|
Jul 31, 2024
Q2 2024
|
New York State Common Retirement Fund
|
SELL
|
- |
-38.9K- 56.55% |
$586K - $825K
|
29.8K
$884K
|
|
|
Aug 14, 2024
Q2 2024
|
Barclays PLC
London, X0 |
SELL
|
- |
-56.7K- 65.01% |
$855K - $1.2M
|
30.5K
$904K
|
|
|
Aug 14, 2024
Q2 2024
|
Parkman Healthcare Partners LLC
Stamford, CT |
SELL
|
- |
-79.1K- 12.11% |
$1.19M - $1.68M
|
575K
$17M
|
|
|
Aug 14, 2024
Q2 2024
|
Opaleye Management Inc.
Boston, MA |
SELL
|
- |
-85K- 12.78% |
$1.28M - $1.8M
|
580K
$17.2M
|
|
|
Aug 09, 2024
Q2 2024
|
Nuveen Asset Management, LLC
Chicago, IL |
SELL
|
- |
-94.9K- 28.08% |
$1.43M - $2.01M
|
243K
$7.2M
|
|
|
Aug 14, 2024
Q2 2024
|
Paradigm Biocapital Advisors LP
New York, NY |
SELL
|
- |
-121K- 4.94% |
$1.82M - $2.57M
|
2.33M
$68.9M
|
|
|
Aug 14, 2024
Q2 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-125K- 33.29% |
$1.88M - $2.65M
|
250K
$7.4M
|
|
|
Oct 17, 2024
Q2 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-125K- 33.29% |
$1.88M - $2.65M
|
250K
$7.4M
|
|
|
Aug 13, 2024
Q2 2024
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-125K- 7.16% |
$1.89M - $2.66M
|
1.62M
$48.1M
|
|
|
Aug 14, 2024
Q2 2024
|
D. E. Shaw & Co., Inc.
New York, NY |
SELL
|
- |
-162K- 34.24% |
$2.45M - $3.44M
|
311K
$9.23M
|
|
|
Aug 14, 2024
Q2 2024
|
Schonfeld Strategic Advisors LLC
New York, NY |
SELL
|
- |
-206K- 72.55% |
$3.11M - $4.38M
|
78.1K
$2.31M
|
|
|
Dec 03, 2024
Q2 2024
|
Voya Investment Management LLC
Atlanta, GA |
SELL
|
- |
-275K- 91.88% |
$4.15M - $5.84M
|
24.3K
$720K
|
|
|
Aug 14, 2024
Q2 2024
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-370K- 13.61% |
$5.58M - $7.86M
|
2.35M
$69.6M
|
|
|
Aug 14, 2024
Q2 2024
|
Perceptive Advisors LLC
New York, NY |
SELL
|
- |
-463K- 19.97% |
$6.99M - $9.83M
|
1.86M
$55M
|
|
|
Aug 14, 2024
Q2 2024
|
Viking Global Investors LP
|
SELL
|
- |
-1.86M- 55.64% |
$28M - $39.4M
|
1.48M
$43.9M
|